Principal Financial Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Buy |
336,225
+1,244
| +0.4% | +$10.1K | ﹤0.01% | 1747 |
|
|
2025
Q1 | $2.63M | Buy |
334,981
+71,464
| +27% | +$561K | ﹤0.01% | 1724 |
|
|
2024
Q4 | $3.92M | Buy |
263,517
+7,906
| +3% | +$118K | ﹤0.01% | 1663 |
|
|
2024
Q3 | $3.91M | Sell |
255,611
-18,777
| -7% | -$287K | ﹤0.01% | 1636 |
|
|
2024
Q2 | $4.18M | Sell |
274,388
-15,577
| -5% | -$237K | ﹤0.01% | 1595 |
|
|
2024
Q1 | $5.47M | Sell |
289,965
-42,849
| -13% | -$809K | ﹤0.01% | 1536 |
|
|
2023
Q4 | $6.36M | Buy |
332,814
+3,372
| +1% | +$64.4K | ﹤0.01% | 1478 |
|
|
2023
Q3 | $5.91M | Buy |
329,442
+1,312
| +0.4% | +$23.6K | ﹤0.01% | 1465 |
|
|
2023
Q2 | $6.66M | Buy |
328,130
+3,390
| +1% | +$68.9K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $5.92M | Sell |
324,740
-4,267
| -1% | -$77.8K | ﹤0.01% | 1480 |
|
|
2022
Q4 | $6.8M | Sell |
329,007
-12,199
| -4% | -$252K | 0.01% | 1424 |
|
|
2022
Q3 | $8.93M | Buy |
341,206
+9,429
| +3% | +$247K | 0.01% | 1248 |
|
|
2022
Q2 | $8.41M | Buy |
331,777
+323,465
| +3,892% | +$8.2M | 0.01% | 1347 |
|
|
2022
Q1 | $262K | Sell |
8,312
-268
| -3% | -$8.45K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $347K | Sell |
8,580
-5,499
| -39% | -$222K | ﹤0.01% | 2211 |
|
|
2021
Q3 | $491K | Sell |
14,079
-2,283
| -14% | -$79.6K | ﹤0.01% | 2176 |
|
|
2021
Q2 | $449K | Sell |
16,362
-7,052
| -30% | -$194K | ﹤0.01% | 2240 |
|
|
2021
Q1 | $657K | Sell |
23,414
-666
| -3% | -$18.7K | ﹤0.01% | 2085 |
|
|
2020
Q4 | $625K | Buy |
+24,080
| New | +$625K | ﹤0.01% | 2055 |
|